PatchClamp MedTech, Inc.

PATCHCLAMP -  A DEVICE FOR THE REPAIR AND SEALING OF DURA IN MINIMALLY INVASIVE SURGERY (MIS) PROCEDURES OF THE BRAIN AND SPINE.

PatchClamp Medtech, Inc. (PMI) is a medical device start-up located in Seattle WA. Dr. Marc Mayberg has developed a patent-protected medical device that addresses a large unmet need in minimally-invasive surgery (MIS) of the brain and spine. PatchClamp has partnered with Seattle-based engineering firm Product Creation Studio www.productcreationstudio.com to create the prototype for a minimally invasive device that will repair and seal MIS incisions of the dura, reducing the risk of infection, improving the speed of closure and accelerating healing after complex neurosurgical cranial/spinal procedures. PatchClamp has received a $500,000 phase-one SBIR grant from the NIH to further develop the proof of concept.

Purpose

We intend to develop an affordable and reliable technology for repairing and sealing durotomies (incisions or punctures in the dura) in MIS procedures of the brain and spine.

Impact

The PatchClamp device will achieve Better Outcomes at a Lower Cost by properly repairing and sealing the dura in restricted surgical exposures.

By addressing the significant unmet need for an effective means to provide an immediate watertight seal for durotomies, the Patchclamp device will provide benefits in several ways:

  • Reduce complications

  • Improve outcomes

  • Lower hospital costs

  • Decrease hospital readmissions

  • Shorten OR time

Product Description

Dr. Mayberg’s 40 years of experience as a Neurosurgeon encompassing more than 3,000 operations led to the conception of PatchClamp, to quickly and effectively repair and provide an immediate watertight seal for openings of the dura encountered in MIS and open surgical procedures. Repair and sealing of the dura that surrounds the brain and spine is critical to prevent leakage of cerebrospinal fluid, which frequently leads to serious complications such as meningitis.

IP Description

Dr. Mayberg and Product Creation Studios have assigned all base IP to PMI resulting from dural repair inventions. PMI has filed and received a patent detailing the PatchClamp tissue-sealing device as of January 2020. A USPTO utility patent and simultaneous Prioritized Patent Examination has been approved as of January 2021. PMI in 2022 applied for international patents, and has received IP protection in Japan.